| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.057 | 0.4 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.4 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.023 | 0.4 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.06 | 0.4 |